Search Results
Department of Breast Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
Search for other papers by Tian Zhou in
Google Scholar
PubMed
Department of Surgery, Second People's Hospital of Guizhou Province, Guiyang, Guizhou, China
Search for other papers by Dai-wei Zhao in
Google Scholar
PubMed
Search for other papers by Ning Ma in
Google Scholar
PubMed
Search for other papers by Xue-ying Zhu in
Google Scholar
PubMed
Search for other papers by Xing-hong Chen in
Google Scholar
PubMed
Search for other papers by Xue Luo in
Google Scholar
PubMed
Search for other papers by Song Chen in
Google Scholar
PubMed
Search for other papers by Qing-jun Gao in
Google Scholar
PubMed
Objective
Thyroid cancer (THCA) is the most common endocrine cancer in the world. Although most patients with THCA have a good prognosis, the prognosis of those with THCA who have an extra-glandular invasion, vascular invasion, and distant metastasis is poor. Therefore, it is very important to find potential biomarkers that can effectively predict the prognosis and progression of highly aggressive THCAs. It has been identified that forkhead box P4 (FOXP4) may be a new biomarker for the proliferation and prognosis for tumor diagnosis. However, the expression and function of FOXP4 in THCA remain to be determined.
Methods
In the present study, the function of FOXP4 in cells was investigated through the comprehensive analysis of data in The Cancer Genome Atlas and combined with experiments including immunohistochemistry (IHC), colony formation, Cell Counting Kit-8 assay, wound scratch healing, and transwell invasion assay.
Results
In the present study, relevant bioinformatic data showed that FOXP4 was highly expressed in THCA, which was consistent with the results of the IHC and cell experiments. Meanwhile, 10 FOXP4-related hub genes were identified as potential diagnostic genes for THCA. It was found in further experiments that FOXP4 was located in the nucleus of THCA cells, and the expression of FOXP4 in the nucleus was higher than that in the cytoplasm. FOXP4 knockdown inhibited in vitro proliferation of the THCA cells, whereas overexpression promoted the proliferation and migration of THCA cells. Furthermore, deficiency of FOXP4 induced cell-cycle arrest.
Conclusion
FOXP4 might be a potential target for diagnosing and treating THCA.
Department of Endocrinology, Zunyi Medical University, Zunyi, China
Search for other papers by Mengxue Yang in
Google Scholar
PubMed
Search for other papers by Bowen Sun in
Google Scholar
PubMed
Search for other papers by Jianhui Li in
Google Scholar
PubMed
Search for other papers by Bo Yang in
Google Scholar
PubMed
Search for other papers by Jie Xu in
Google Scholar
PubMed
Search for other papers by Xue Zhou in
Google Scholar
PubMed
Search for other papers by Jie Yu in
Google Scholar
PubMed
Search for other papers by Xuan Zhang in
Google Scholar
PubMed
Search for other papers by Qun Zhang in
Google Scholar
PubMed
Search for other papers by Shan Zhou in
Google Scholar
PubMed
Search for other papers by Xiaohua Sun in
Google Scholar
PubMed
Objectives
The pathogenesis of Graves’ disease (GD) remains unclear. In terms of environmental factors, GD development may be associated with chronic inflammation caused by alteration of the intestinal flora. This study explored the association of intestinal flora alteration with the development of GD among the Han population in southwest China.
Design and methods
Fifteen GD patients at the Affiliated Hospital of Zunyi Medical College between March 2016 and March 2017 were randomly enrolled. Additionally, 15 sex- and age-matched healthy volunteers were selected as the control group during the same period. Fresh stool samples were collected, and bacterial 16S RNA was extracted and amplified for gene sequencing with the Illumina MiSeq platform. The sequencing results were subjected to operational taxonomic unit-based classification, classification verification, alpha diversity analysis, taxonomic composition analysis and partial least squares-discriminant analysis (PLS-DA).
Results
The diversity indices for the GD group were lower than those for the control group. The GD group showed significantly higher abundances of Firmicutes, Proteobacteria and Actinobacillus and a higher Firmicutes/Bacteroidetes ratio than the control group. PLS-DA suggested the satisfactory classification of the flora between the GD group and the control group. The abundances of the genera Oribacterium, Mogibacterium, Lactobacillus, Aggregatibacter and Mogibacterium were significantly higher in the GD group than in the control group (P < 0.05).
Conclusions
The intestinal flora of GD patients was significantly different from that of the healthy population. Thus, alteration of intestinal flora may be associated with the development of GD.
Search for other papers by Peng Fan in
Google Scholar
PubMed
Search for other papers by Chao-Xia Lu in
Google Scholar
PubMed
Search for other papers by Di Zhang in
Google Scholar
PubMed
Search for other papers by Kun-Qi Yang in
Google Scholar
PubMed
Search for other papers by Pei-Pei Lu in
Google Scholar
PubMed
Search for other papers by Ying Zhang in
Google Scholar
PubMed
Search for other papers by Xu Meng in
Google Scholar
PubMed
Search for other papers by Su-Fang Hao in
Google Scholar
PubMed
Search for other papers by Fang Luo in
Google Scholar
PubMed
Search for other papers by Ya-Xin Liu in
Google Scholar
PubMed
Search for other papers by Hui-Min Zhang in
Google Scholar
PubMed
Search for other papers by Lei Song in
Google Scholar
PubMed
Search for other papers by Jun Cai in
Google Scholar
PubMed
Search for other papers by Xue Zhang in
Google Scholar
PubMed
Search for other papers by Xian-Liang Zhou in
Google Scholar
PubMed
Liddle syndrome (LS), a monogenetic autosomal dominant disorder, is mainly characterized by early-onset hypertension and hypokalemia. Clinically, misdiagnosis or missing diagnosis is common, since clinical phenotypes of LS are variable and nonspecific. We report a family with misdiagnosis of primary aldosteronism (PA), but identify as LS with a pathogenic frameshift mutation of the epithelial sodium channel (ENaC) β subunit. DNA samples were collected from a 32-year-old proband and 31 other relatives in the same family. A designed panel including 41 genes associated with monogenic hypertension was screened using next-generation sequencing. The best candidate disease-causing variants were verified by Sanger sequencing. Genetic analysis of the proband revealed a novel frameshift mutation c.1838delC (p.Pro613Glnfs*675) in exon 13 of SCNN1B. This heterozygous mutation involved the deletion of a cytosine from a string of three consecutive cytosines located at codons 612 to 613 and resulted in deletion of the crucial PY motif and elongation of the β-ENaC protein. The identical mutation was also found in 12 affected family members. Amiloride was effective in alleviating LS for patients. There were no SCNN1A or SCNN1G mutations in this family. Our study emphasizes the importance of considering LS in the differential diagnosis of early-onset hypertension. The identification of a novel frameshift mutation of SCNN1B enriches the genetic spectrum of LS and has allowed treatment of this affected family to prevent severe complications.
